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Abstract Resumen Resumo
AMBER/PM3 hybrid model allowed determining 
the structural properties of 5FU and imiquimod 
individually and after the adsorption in 
chitosan hydrogels crosslinked with genipin, 
respectively. It was observed that the Gibbs 
free energy (ΔG) decreases with the adsorption, 
but indicates thermodynamic stability and 
spontaneity in both processes; ΔG was verified 
by the increase in the dipole moments. On the 
one hand the partition coefficient established 
the hydrophilic character with respect to the 
water present in the hydrogel, which increases 
with the adsorption. The FTIR showed that 
there were displacements in the signals, 
however, the hydrogen bond bands attributed 
to the formation of new bonds to perform 
the adsorption of the drugs were observed. 
The adsorption was verified by the MESP and 
the surface analysis, where the distribution 
of nucleophilic and electrophilic zone was 
observed.
El modelo hibrido AMBER/PM3 permitió 
determinar las propiedades estructurales del 
5FU e imiquimod individualmente y después 
de la adsorción en hidrogeles de quitosano 
entrecruzados con genipina, respectivamente. 
Se observó que la energía libre de Gibbs (ΔG) 
disminuye con la adsorción, sin embargo, 
en ambos procesos se encontró estabilidad 
termodinámica y espontaneidad; ΔG fue 
verificado mediante el incremento en los 
momentos dipolares. Por otro lado, el 
coeficiente de partición estableció el carácter 
hidrofìlico con respecto al agua presente en el 
hidrogel, el cual aumenta con la adsorción. El 
FTIR evidenció que existen desplazamientos 
en las señales. Se observaron las bandas de 
puente de hidrógeno, atribuidas a la formación 
de enlaces, para realizar la adsorción de los 
fármacos. La adsorción fue verificada mediante 
los MESP y los análisis de superficie, en donde 
se apreció la distribución de zonas nucleofílicas 
y electrofílicas.
O modelo hibrido AMBER/PM3 permitiu 
determinar as propriedades estruturadas do 
5FU e imiquimod individualmente e depois 
da adsorção em hidrogeles de quitosano 
entrecruzados com genipina, respectivamente. 
Observou-se que o poder livre de Gibbs (ΔG) 
diminui com a adsorção, sem embargo, em 
ambos os processos se encontró estabilidade 
termodinâmica e espontaneidad; ΔG foi 
verificado através do aumento nos momentos 
de dipolares. Por outro lado, o coeficiente de 
divisão estabeleceu o carácter hidrofílico em 
relação à água presente no hidrogel, o qual 
aumenta com a adsorção. El FTIR evidenció 
que existem deslocamentos em las señales. 
Se observe as bandas de puente de hidrógeno, 
atribuições à formação de enlaces, para 
realizar a adsorção dos fármacos. A adsorção 
foi verificada através do MESP e os análises de 
superfície, em donde se apreciou a distribuição 
de zonas nucleofílicas e eletrofílicas.
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Introduction
Nanomedicine is the science that applies nanotechnology. It is of major 
importance due to the early detection of diseases, making it possible to 
develop nanosystems for the treatment of diseases using the design of new 
drugs and carriers (1–4).The main applications of nanomedicine are the 
controlled release systems and the diagnoses of diseases as well as imaging 
analysis. Nanometric scale controlled delivery systems have the objective 
of transporting and releasing drug in a specific place obtaining a treatment 
of greater effectiveness (5, 6). For this purpose hydrogels are used due to a 
greater affinity in the adsorption and release of the drug, the biocompatibility 
with the human body, biodegradability, the permeability, non–toxicity (1–3, 
7), and the adhesiveness of the three–dimensional structure that allows the 
hydrogels to be used in the processes of skin healing and cancer treatments 
(8).
In the last five years, the skin cancer treated by surgery had an 80% 
mortality rate. The main types of skin cancer are basal cells (BCC), 
squamous cells (SCC), and malignant melanoma. The drugs most often 
used in skin cancer therapies are 5–fluorouracil (5FU) and imiquimod.
5FU is an antimetabolite whose function is to inhibit the metabolic 
process of the cells generating cell death at the stage of mitosis (9). The 
antimetabolites have a structure very similar to the normal molecules of the 
human body (10).The structure consists of an organic aromatic heterocyclic 
with a fluorine atom in carbon 5. Due to its structure, 5FU interferes with 
nucleoside metabolism and can be incorporated into the RNA and DNA 
chains, leading to cytotoxicity and cell death. Its active form inhibits DNA 
synthesis by inhibiting the normal production of thymidine. It is primarily 
used for colon, chest, and neck cancer treatments (11, 12).
5FU is used in a cream form for treatments of actinic keratosis and 
basal cell carcinoma; however, in an injected form it produces effects in the 
central nervous system. 
The effectiveness is attributed to the irreversible union with the enzyme 
thymidylate synthase, essential during the synthesis of thymine nuclei, 
which is one of the main nitrogenous bases that constitute the DNA, , and 
without the nuclei thymine the DNA cannot multiply, thus cannot produce 
tumor growth (10).
Imiquimod is a compound also known as imidazoquinolones (13). It has 
the function of modifying the immune response in the body by stimulating 
the immune system to release cytokines due to the formation of an alpha-
type interferon (IFN-α), as well as tumor necrosis factor-α (TNF-α) and, 
proinflammatory cytokines attributed to the heterocyclic structure. It also 
does not have stereoisomerism (14, 15).
Imiquimod in contact with the skin activates macrophages, type B 
lymphocytes and Langerhans cells that cause the activation of the immune 
system in the lymph nodes (15, 16). It is widely used in the treatment of 
skin cancer for the removal of superficial basal cell carcinoma (BCC) (14, 
15). It is also known for its excellent antiviral and antitumor activity (13). 
Imiquimod cream is used in actinic keratosis treatments, ie, flat, scaly 
growths on the skin caused by excessive exposure to UV rays on the face, 
scalp, neck, arms, hands, legs, and warts in the genital and anal areas.
Computational chemistry has allowed studying, understanding, 
and designing nanometric scale new controlled delivery systems for 
pharmaceutical applications.For example, the adsorption of drugs in 
chitosan hydrogels has been studied to predict structural, chemical, and 
physical properties, FTIR, UV, and NMR at the nanometric scale (8, 17). 
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Computational chemistry consists of two principal areas: molecular 
or classical mechanics (MM) and quantum mechanics (QM). The analysis 
in MM requires the calculation of approximations primarily the Born–
Oppenheimer. 
In addition, Hooke's law is used as an approximation because the 
bonds between the atoms are a function of the harmonic potential as well 
as the transferability of the force field such as Assisted Model Building 
with Energy Refinement(AMBER), Chemistry at Harvard Macromolecular 
Mechanics (CHARMM), MM1, MM2, MM3 or MM4 (18, 19). AMBER 
has also been designed with the purpose of studying pharmaceutical 
molecules. It allows for analysis in large areas of the conformational space 
with greater precision and lower computational cost as compared to Density 
Functional Theory (DFT) or Molecular Dynamic (MD) (20, 21).
QM is widely used to study molecular interactions in new controlled 
release systems. QM performs the calculations from the nucleo-electron 
interactions because it is based on the Schrodinger’s equation (22). Semi-
empirical methods have the basis of calculation of Hartree-Fock (HF) in 
which the Hamiltonian and the wave function, respectively, are involved. 
It should be noted that a parameterization is established for the elimination 
of the calculation errors, which obtains data close to experimental results in 
the optimization geometry, dipole moments, reaction heats, ionization and 
electrostatic potentials and electronic spectra. 
The parametrization method 3 (PM3) has a greater precision in the 
measurement of lengths and angles of bond is also efficient for the solvation 
reactions (23). The pharmaceutical industry has increased the modelling of a 
dataset by using quantum mechanics in the design of new controlled release 
systems to predict chemical properties, biological activity, toxicology, and 
pharmacokinetics and pharmacodynamics to analyze the release of drugs 
in hydrophilic matrices for the treatment of diseases (24–25). On the other 
hand the prediction of structural relations–biological activity (QSAR) 
in the pharmaceutical industry has represented an increase in the use of 
computational tools due to the information obtained as the molecular 
interactions, the biological behavior, structural properties, electrostatic and 
the distribution of charges for the design of the controlled release system. 
The objective of this research was to determine the most stable 
molecular configuration in the adsorption process of the 5FU and imiquimod 
in chitosan hydrogels respectively, using the AMBER/PM3 hybrid model.
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The calculation of the optimization geometry of 5FU, imiquimod, 5FU/
hydrogel, and imiquimod/hydrogel was carried out on a DELL I5 computer. 
Using the HyperChem software, the AMBER model of molecular 
mechanics was firstly selected using the conjugate gradient method with a 
Polak–Ribiere algorithm and Root Mean Square (RMS) of 0.001 Kcal/Å–
mol, respectively. Later, the calculation was performed using the PM3 
model of quantum mechanics under the same conditions. The PM3 model 
allows for a better analysis of the hydrogen bonds and the effects attributed 
to the steric interactions. The purpose of this combination was to refine 
the molecular geometry, then to obtain an overall minimum in molecular 
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Table 4 shows the vibrations of FTIR of the hydrogel (chitosan/genipin) 
where it is observed that the vibrations at 2320 and 1097 cm−1 were attributed 
to the cross-linking of the chitosan with genipin. The signal at 1097 cm−1 
was assigned to the CN bond produced from the reaction of lysine with 
genipin, while the signal at 2320 cm-1 corresponded to the C-C, C-H, C-O, 
and C-N bonds obtained after cross-linking (37, 38). The C=O stretching 
band of chitosan amide I at 1691 cm−1 was attributed to the cross-linking 
due to overlapping with C=C stretching with the genipin structure (39).
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QSAR properties
HyperChem has the QSAR properties module in the Compute menu, where 
properties related to biological activity can be obtained. In controlled 
delivery systems, the partition coefficient parameter (Log P) shows the 
octanol/water ratio to determine whether the molecule is hydrophilic 
or hydrophobic in order to evaluate the similarity of the drug with a 
pharmacological or biological activity that could make it a possible active 
drug in the human body (27, 28). Table 1 shows the ΔG (free energy of 
Gibbs) and the Log P of 5FU and the imiquimod calculated with the hybrid 
model AMBER/PM3 in which the negative negative value of the G indicates 
thermodynamic stability. 
The Log P negative indicates that there is an affinity to the water 
contained in the hydrogel. On the other hand the positive value indicates 
that there are many factors affecting the adsorption like interaction forces 
between drugs and water that may involve electrostatic interactions, Van 
der Waals interactions, chemical affinity, and hydrogen bonds (28–30).
Properties Units 5FU Imiquimod
ΔG Kcal/mol – 43180.10 – 58905.50
Dipole moment Debyes 3.570 4.522
Log P ---------- – 1.78 0.82
Table 1. 5FU and Imiquimod properties.
FTIR spectrum
From the Compute menu, the Vibration and rotation analysis option was 
selected and once the calculation was completed through the Compute–
Vibrational spectrum option. The FTIR spectrum was selected and the 
vibrational mode was chosen by observing the different vibrational modes 
at several wavelengths (26). Table 2 shows the FTIR vibrations about 5FU 
in where, at3021 and 906cm–1, were attributed to CH stretching vibrations, 
in the range between 1946–1901cm–1 and 331–124 cm–1appeared band 
of carbonyl stretching (C=O). The peak at 1180 cm–1 belonged to C–F 
stretching band in the molecule of 5FU (11, 31, 32).
The FTIR vibrations of imiquimod structure are presented in Table 3 
in where the CH stretching was observed at 3076–2871 cm−1.The carbonyl 
stretching was localized at 1894–1647 cm−1 (strong and narrow).Finally, the 
C–C stretching was observed between 890–795 and 520–433 cm−1. 
Bond Vibration Theoretical (cm-1) Experimental (cm-1)
N–H Stretching 3491, 3184, 789 3516, 3245, 3173
C–H Stretching 3250–3168, 1015 3425, 3062
C=O Stretching 1915–1876, 1715 1720, 1707
C=C Stretching 1749 1743, 1649
C–N Stretching 1564–1387, 1209–711 1650, 1580, 1038
C–F Stretching 1214 1337, 1275, 1222
C–H Stretching 1210 1243
C–F Wagging 615–598, 459–311 804
Table 2. FTIR vibrations of 5FU by AMBER/PM3 hybrid model.
Bond Vibration Theoretical (cm-1)
Experimental 
(cm-1) (36)
N–H Symmetric stretching 3537–3429 3392
C–H Asymmetric stretching 3076–2871 2960
C=O Stretching 1894–1647 1668
C=C Stretching 1782–1694 1531
C–C Wagging 890–795, 520–433 960-875, 725-720
C–H Wagging 795 730-710
Table 3. FTIR vibrations of imiquimod by AMBER/PM3 hybrid model.
Bond Vibration Theoretical (cm-1) Experimental (cm-1)
OH and CH Stretching 3676 3859, 3550
CH Stretching 4901, 3885 3745
C=C Stretching 3354, 1687 3398, 3245, 1630-1620
NH Stretching 3314, 1545 3458, 3315, 3295, 1580
C-C, C-O Stretching 2680, 2571, 1909, 1133, 489 2520, 1295, 1150, 793
CN Stretching 1400, 1000 1360-1080
CC, CO, CH Stretching 1445, 813 3089, 1440, 990, 721
C=O Stretching 1691 1630
Table 4. FTIR vibrations of Hydrogel by AMBER/PM3 hybrid model.
MESP (Molecular Electrostatic Potential)
Once the FTIR spectrum was obtained, the three–dimensional contour 
diagram with the electronic distribution of the molecule was obtained from 
the Compute menu and the plot molecular graphs option. 
MESP was made with the objective of observing the nucleophilic and 
electrophilic zones, in addition to the distribution of the electron density 
of the HOMO and LUMO molecular orbitals (40). Figure 1 shows that the 
negative or electrophilic zones correspond to the C=O and C–F bonds in 
the 5FU as well as the C=N bond of the imiquimod, whereas the positive 
or nucleophilic zones are attributed to the NH and CH bonds, respectively.
One of the objectives of the use of hydrogels in the design of new controlled 
release systems is to obtain a better vectorization and increase in the union 
of the soluble set with specific drugs (41). Table 5 shows Gibbs free energy 
(ΔG) which was calculated using the AMBER/PM3 hybrid model. This 
information allows analyzing the reaction mechanism for the formation of 
covalent bonds between the surface of the hydrogel and the drugs, allowing 
an increase on the affinity and maintaining the required pharmaceutical 
molecule size at the same time.Therefore, covalent drug interaction would 
increase the release of the biological effect. 
A negative ΔG is also observed in both drugs indicating that the 
adsorption process is carried out spontaneously. 
ΔG is attributed to the swelling of the chains of chitosan in the hydrogel 
due to the increase in volume during the adsorption, producing that the 
drugs to be diffused through the swollen hydrogel (19) due to the presence 
of sp3 and sp2 hybridizations responsible for the molecular recognition and 
stability of the drugs in both hydrogels as derivatives of the dispersion 
forces (42).
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During the first stage, the adsorption mechanism is slow due to the 
barrier that generates the swelling affecting the diffusion of the drugs in 
addition to the covalent bonds responsible for the cross–linking of the 
hydrogels. It should be noted that the negative Log P indicates an increase in 
hydrophilic properties and electrostatic repulsion responsible for swelling 
of the hydrogel and subsequent adsorption of each drug (44). Although the 
fluorine atom causes low polarizabilities, it generates an increase in the 
hydrophilic capacity due to the rise of the dispersion forces in the hydrogel 
(45).
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Table 6 and Figure 2 show the main adsorption vibrations of 5FU in 
the hydrogel, in which the adsorption is verified by the displacements 
of the signals in the fingerprint region of the drug. The adsorption band 
characteristic at 1952 cm-1 was attributed to the symmetric C=O stretching.
This band is very strong due to the change in the dipole moment as seen in 
Tables 1 and 5. The C–H stretching is indicative of the adsorption process 
where the range of 3000 to 2728 cm-1 was attributed to sp3 hybridizations 
and above 3000 cm-1 corresponds to sp2 hybridizations. When approaching 
3200 cm-1frequencies are assigned to the sp hybridization (46). The band 
at 1838 cm-1 is assigned to C=C stretching mode. Bands at 1457 cm-1 
corresponded to N–H wagging, meanwhile the C–H wagging was observed 
at 1142 cm-1, and the stretching C–F was observed at 1235–1189 cm-1. 
Finally, fluorine atom in the hydrogel produces a displacement of the uracil 
ring from 795–789 to 778 cm-1 (47).
Table 7 and Figure 3 show that the adsorption of imiquimod is 
attributed to the formation of the hydrogen bond through the symmetrical 
and asymmetric stretching of the CH of the drug and the OH of the chitosan 
present in the hydrogel in the regions of 3893–3811 and 3792–3764 cm-
1. The bands between 2980 and 2965 cm-1 were assigned to the presence 
of C–H bonds (asymmetric and symmetric stretching). Those bonds were 
attributed to the presence of alkyl chain from the imiquimod on the surface 
of the hydrogel. The presence of the imiquimod amines was assigned in 
the 3586–3429 cm-1. The amide I and II vibrations of the chitosan were 
observed at 3261, 1667–1661, 1533, 846, 808, 759, and 210 cm-1,however, 
there is the presence of an overlap at 1661 cm-1 attributed to the amides 
secondary effects of imiquimod. In addition, a shift in these bands is 
due to the formation of NH2–NH3+ iterations of the water present in the 
hydrogel and the amines. The stretching of the O–H bond of the hydrogel 
was observed at 1564, 1467, 1400, 1367, 503–470, and 372–235 cm-1, 
respectively (48, 49).
FTIR
Figure 1. MESP of (a) 5FU and (b) Imiquimod by AMBER/PM3 hybrid model.
Results and Discussion
Structural properties
Properties Units 5FU/hydrogel Imiquimod/ hydrogel
ΔG Kcal/mol – 22128.032 – 24459.301
Dipole moment Debyes 5.121 8.193
Log P --------- – 15.04 – 13.59
Table 5.Structural properties of the adsorption process of 5FU and Imiqui-
modin the hydrogel by AMBER/PM3 hybrid model.
The change in the dipole moment (see Tables 1 and 5) is attributed 
to the electronegativity of the fluorine atom and C=N bond of 5FU and 
imiquimod, respectively. It indicates that there is an adsorption of the drugs 
on the surface of the hydrogel where there are Van der Waals forces or 
London dispersion forces (43). 
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Table 6. FTIR vibrations of adsorption process of 5FU in the hydrogel by 
AMBER/PM3 hybrid model.
Table 7. FTIR vibrations of adsorption process of Imiquimod in hydrogels 
by AMBER/PM3 hybrid model.
Figure 2. 5FU spectrum in where (a) before and (b) after the adsorption process in the hydrogel.
Bond Wavelength(cm-1) Vibration
O–H 3868–3836 Stretching (chitosan)
O–H 3764 Stretching (hydrogel/drug)
N–H 3528–3497 Symmetric stretching (chitosan)
N–H 3391 Asymmetric stretching (chitosan)
N–H 3324 Stretching (drug)
C–H 3127–2728 Stretching (hydrogel/drug)
C=O 1952 Symmetric stretching (drug)
C=O 1933–1919 Stretching (chitosan)
C=O 1919 Stretching (hydrogel)
C=C 1869, 1833 Stretching (genipin)
C=O 1860 Stretching (hydrogel/drug)
C=C 1838 Stretching (drug)
N–H 1457 Wagging (drug)
N–H 1667–1655 Scissoring (chitosan)
C–C 1460 Stretching (chitosan)
C–N 1379 Stretching (drug)
C–H 1142 Wagging (drug)
C–F 1235–1189 Stretching (C–F)
N–H, C–H 778 Wagging (hydrogel/drug)
N–H 639 Wagging (chitosan)
O–H 549 Wagging (chitosan)
C=O 523 Wagging (hydrogel/drug)
C=O 498 Wagging (drug)
O–H 439–176 Wagging (chitosan)
C–O 147–20 Wagging (chitosan)
Bond Wavelength (cm-1) Vibration
O–H 3893–3811, 3792–3764 Stretching (hydrogel/drug)
N–H 3586–3429 Symmetric stretching (drug)
N–H 3261 Stretching (hydrogel)
C–H 3110, 2970 Stretching (hydrogel)
C–H 3042, 2916 Stretching (drug)
C–H 2980–2965 Stretching (hydrogel/drug)
C=C 1803–1695, 1558 Stretching (drug)
N–H 1667–1661, 210 Scissoring (chitosan)
N–H 1661 Scissoring (drug)
C=N 1602–1580, 1518 Stretching (drug)
C–N 1580, 1558, 1482, 1446, 1440 Stretching (drug)
O–H 1564, 1467, 1400, 1367, 503–470, 372–235 Wagging (hydrogel)
C–C 1558, 1006, 901 601 Wagging (drug)
N–H 1533, 808, 759 Wagging (chitosan)
C–C 1484–1482, 1423, 1271, 808 Stretching (genipin)
C–H 1250–1070 Stretching (glycoside ring)
C–N 901, 601 Wagging (drug)
N–H 846 Wagging (drug)
Structural properties
Figures 4a–5a show that the MESP attributed the local maxima corresponding 
to the electrophilic zones while the local minima were associated with the 
nucleophilic zones.The zones are defined through the zero–flow surface 
bounded by the saddle points (50).
Rev. Colomb. Quim. 2018, 47 (2), 28-35.
Structural analysis of adsorption processes of 5FU and imiquimod on hydrogels using AMBER/PM3 hybrid model
33
Figure 3. Imiquimod spectrum in where (a) before and (b) after the adsorption process in the hydrogel.
Figure 4. Maps of5 FU adsorption on chitosan hydrogel in where, (a) MESP and b) Surface energy respectively.
Figure 5. Maps of Imiquimod adsorption on chitosan hydrogel in where, (a) MESP and b) Surface energy respectively.
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In addition, Figure 4a shows that the electrostatic distribution of the 
5FU adsorption in the hydrogel had values ranging from 1.172 to -0.030 
eV, where the electronegativity of the fluorine atom (yellow color) 
modifies the distribution of the electronic density that produces a decrease 
of electrons i.e. an oxidation (51) causing the formation of the hydrogen 
bridge bond at the surface of the hydrogel during the adsorption process 
(52). In pharmaceutical applications, the surface energy calculations 
observed in Figures 4b–5b are intended to determine the wettability and 
adhesion properties by the molecular interactions involved in the adsorption 
process such as cohesion, adhesion, mucoadhesion, and dispersion (53).The 
MESP of imiquimod adsorption is shown in Figure 5 where the electron 
distribution (0.988 to –0.025 eV) shows an increase in the nucleophilic 
zones due to the formation of hydrogen bonds during the adsorption as well 
as to electrostatic interactions and non–polar forces (54).
Conclusions
The AMBER/PM3 hybrid model of the molecular simulation allowed a 
complete analysis of the structure of the molecule through the identification 
of conformations of the hydrogel/drug adsorption. The Gibbs free energy 
determined that there is an adsorption of each drug and was verified because 
the greater the dipole moment, the greater the adsorption efficiency due 
to the electronegativity present in the drugs. FTIR showed the electronic 
distribution where the formation of hydrogen bonds between the hydrogel 
and the hydroxyl and amine groups of the drugs was observed. MESP 
showed that the difference seen in the values of the electronic distribution 
was attributed to the electronegative character of the bonds C-F, C=O and 
OH respectively.
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